Results 131 to 140 of about 848 (166)
Some of the next articles are maybe not open access.
International Journal of Dermatology, 2003
AbstractScleromyxedema is a rare disease characterized by papular mucinous deposits, dermal fibroblast proliferation, and a monoclonal paraproteinemia. Its chronic course tends to be complicated by gastrointestinal, muscular, pulmonary, and neurologic disorders.
John J, Pomann, Earl J, Rudner
openaire +2 more sources
AbstractScleromyxedema is a rare disease characterized by papular mucinous deposits, dermal fibroblast proliferation, and a monoclonal paraproteinemia. Its chronic course tends to be complicated by gastrointestinal, muscular, pulmonary, and neurologic disorders.
John J, Pomann, Earl J, Rudner
openaire +2 more sources
Ophthalmic Plastic & Reconstructive Surgery, 2015
Scleromyxedema is characterized by cutaneous mucinosis and rarely presents to oculoplastic surgeons with bilateral upper and lower eyelid swelling. The authors present 2 case reports with a review of the literature and discuss the ophthalmic manifestations of scleromyxedema and the management of these cases.
Farhan, Qureshi +2 more
openaire +2 more sources
Scleromyxedema is characterized by cutaneous mucinosis and rarely presents to oculoplastic surgeons with bilateral upper and lower eyelid swelling. The authors present 2 case reports with a review of the literature and discuss the ophthalmic manifestations of scleromyxedema and the management of these cases.
Farhan, Qureshi +2 more
openaire +2 more sources
Advances in understanding and treatment of scleromyxedema
Expert Opinion on Orphan Drugs, 2018 Introduction: Scleromyxedema is a rare fibromucinosis, associated with monoclonal gammopathy, and other comorbidities with unpredictable prognosis. It usually affects middle-aged adults, without gender predilection.
Franco Rongioletti
exaly +2 more sources
Archives of Dermatology, 1976
An unusual, nodulocystic form of scleromyxedema (lichen myxedematosus) developed in a 48-year-old man with a six-year history of psoriasis. The scleromyxedema responded to intermittent therapy with melphalan and prednisone. Dermabrasion smoothed and softened the skin and increased the mobility of the perioral skin.
R C, Wright +3 more
openaire +3 more sources
An unusual, nodulocystic form of scleromyxedema (lichen myxedematosus) developed in a 48-year-old man with a six-year history of psoriasis. The scleromyxedema responded to intermittent therapy with melphalan and prednisone. Dermabrasion smoothed and softened the skin and increased the mobility of the perioral skin.
R C, Wright +3 more
openaire +3 more sources
Archives of Dermatology, 1966
Two patients with typical skin lesions of scleromyxedema (lichen myxedematosus) are described. The disorder is characterized by proliferation of fibroblasts and excessive deposition of acid mucopolysaccharides in the dermis. Quantitative elevated levels of acid mucopolysaccharides were demonstrated in the serum and skin of one patient.
openaire +1 more source
Two patients with typical skin lesions of scleromyxedema (lichen myxedematosus) are described. The disorder is characterized by proliferation of fibroblasts and excessive deposition of acid mucopolysaccharides in the dermis. Quantitative elevated levels of acid mucopolysaccharides were demonstrated in the serum and skin of one patient.
openaire +1 more source
Dermatologie (Heidelberg, Germany)
Scleromyxedema or generalized diffuse lichen myxoedematosus is a rare mucinosis that is associated with monoclonal gammopathy and which frequently affects multiple extracutaneous organ systems. The pathogenesis of scleromyxedema has not been fully elucidated, but includes stimulation of glycosaminoglycan synthesis. The clinical course of scleromyxedema
Cord, Sunderkötter +2 more
openaire +3 more sources
Scleromyxedema or generalized diffuse lichen myxoedematosus is a rare mucinosis that is associated with monoclonal gammopathy and which frequently affects multiple extracutaneous organ systems. The pathogenesis of scleromyxedema has not been fully elucidated, but includes stimulation of glycosaminoglycan synthesis. The clinical course of scleromyxedema
Cord, Sunderkötter +2 more
openaire +3 more sources
New England Journal of Medicine, 2023
Soumya Chatterjee, Anthony P. Fernandez
openaire +2 more sources
Soumya Chatterjee, Anthony P. Fernandez
openaire +2 more sources